During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Patients treated in an outpatient setting who later required admission spent an average of 12.1 days in the hospital, ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

The immune system is made up of different types of cells, which have different roles in protecting the body from infection. One type of immune cell called a B cell creates antibodies that attack ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Doctors at AIIMS, Delhi, are working on a cost-effective antibody-based adaptive cellular therapy for treating multiple myeloma, a form of blood cancer. This innovative approach aims to make advanced ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...